Cells, Allogeneic
- Name
- Cells, Allogeneic
- Accession Number
- DBCAT004450
- Description
Not Available
- Drugs
Drug Drug Description Omidubicel A nicotinamide-modified allogeneic hematopoietic progenitor cell therapy derived from cord blood indicated for use in patients with hematologic malignancies who are planned for umbilical cord blood transplantation following myeloablative conditioning. - Drugs & Drug Targets
Drug Target Type